The global sales of neurovascular access catheters are anticipated to grow at steady CAGR of around 4.8% and 5% between 2022 and 2032, generating considerable revenues by the end of the forecast period. Growth in the market is driven by increasing incidence of various neurovascular diseases and rise in the number of neurovascular procedures performed worldwide.
| Report Attribute | Details |
| Neurovascular Access Catheters Market Projected Growth Rate (2022-2032) | 4.8% - 5% CAGR |
The introduction of novel neurovascular access catheters has significantly revolutionized the treatment methods of neurovascular diseases. They have enabled treatment of even those diseases or conditions that were previously considered untreatable or difficult to treat.
Neurovascular access catheters are being increasingly used to allow blood to be drawn from or medication (including intravenous fluids, drugs or blood transfusions) to be delivered into a patient’s bloodstream. They are particularly ideal for delivering therapeutics as well as for revascularization purposes. These neurovascular access catheters help the medical professional or surgeons to access even distant and peripheral locations, support equipment delivery, and also aid in diagnosing and treating various neurovascular diseases such as brain aneurysms etc.
Over the last few decades, neurovascular access catheters have become essential surgical equipment used in neurovascular and endovascular procedures. Increase in the number of these procedures for treating various neurovascular diseases will therefore continue to push the sales of neurovascular access catheters during the forecast period.
Another factor fueling the adoption of neurovascular access catheters is their customizable nature. These catheters can be easily customized and moulded into different configurations depending on the end user requirements.
Neurovascular access catheters such as central venous catheters, peripheral catheters, and neurovascular access catheters are being increasingly used to assist IV therapy.
Similarly, rising applications of neurovascular access catheters in removing unwanted body fluids from the neurovascular organs including brain and carotid artery and in preventing embolic stroke is anticipated to boost market growth during the forthcoming years,
The robust expansion of neurovascular access catheters market is attributed to the rising prevalence of neurovascular disorders and strokes worldwide, growing health awareness among people, rise in the number of neurovascular and endovascular interventions performed, innovations in catheters material and design, and rapid growth of end use verticals.
Neurovascular access catheters have become highly sought-after medical equipments used during medical procedures for delivering intravenous fluids, blood transfusions, chemotherapy and medical devices as well for draining away unwanted fluids from various body organs or cavities. They can also be used for embolization purposes and aids in the treatment of several neurovascular diseases.
Rise in the number of neurovascular diseases such as brain aneurysm and carotid artery disease is a major factor spurring the growth of neurovascular access catheters market and the trend is likely to continue during the forecast period.
Similarly, rising application of neurovascular access catheter in stroke management coupled with growing adoption of various neurovascular access catheters for delivering therapeutics and other products will continue to create abundant revenue opportunities for the market players during the assessment period.
Despite its optimistic stance, the global neurovascular access catheters market is facing several obstacles that are likely to challenge its growth during the forecast period. Some of these factors are the biocompatibility issues of neurovascular access catheters, high cost of neurovascular procedures, and various risk factors associated with these catheters such as vessel damage, catheter blockage, and threat of infection spread.
As per FMI, North America will continue to hold its dominant position in the global neurovascular access catheters market during the assessment period, owing to the rising prevalence of neurovascular diseases, growing popularity of minimally invasive procedures, easy availability of advanced products, and heavy presence of leading market players.
Within North America, the U.S. remains the epicenter of neurovascular access catheters sales due to rapid rise in neurovascular and endovascular procedures for treating numerous diseases, rapid expansion of healthcare industry, and favorable government support.
According to the National Institute of Neurological Disorders and Stroke, around 30000 Americans suffer from a brain aneurysm rupture each year. This factor will continue to generate sales prospects for neurovascular access catheters during the forecast period.
According to Future Market Insights, Europe is expected to remain the second most lucrative market for neurovascular access catheters, growing at a moderate CAGR over the forecast period. Growth in the market is attributable to the rising patient pool, high awareness levels among people, presence of leading market players, and rise in the number of neurovascular procedures performed across countries like the United Kingdom, Germany and France.
Europe together with North America accounts for a significant market share of the global neurovascular access catheters market in terms of value. Demand is particularly rising across countries like Germany and the United Kingdom due to increasing prevalence of diseases like brain aneurysm and stroke, rising medical tourism, and presence of favorable reimbursement policies.
Some of the key participants present in the global neurovascular access catheters market include Medtronic Plc, Stryker Corporation, Concentric Medical, Inc., Zeus Industrial Products, Inc., Integer Holdings Corporation, Biomerics, Penumbra, Inc., DePuy Synthes, and RAUMEDIC AG, among others.
The global neurovascular access catheters market is highly competitive in nature due to a large presence of regional and domestic players. These players are continuously upgrading their product portfolios, partnering with end users and strengthening their distribution channels to gain a competitive edge in the market.
| Report Attribute | Details |
| Growth Rate | CAGR of 4.8% - 5% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Product Type:
By Material:
By Design Type:
By End User:
By Region:
FMI projects the global neurovascular access catheters market to grow at around 4.8% to 5% CAGR over the forecast period from 2022 to 2032.
North America is expected to remain the most lucrative market for neurovascular access catheters during the forecast period.
Medtronic Plc, Stryker Corporation, Concentric Medical, Inc., Zeus Industrial Products, Inc., Integer Holdings Corporation, and Biomerics are some prominent manufacturers of neurovascular access catheters.
Explore Similar Insights
Neurovascular Access Catheters Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
